Immunogenicity Safety Study of Wockhardt's Recombinant Insulin Analogue in Type 1 Diabetic Patients

This study is not yet open for participant recruitment. (see Contacts and Locations)
Verified May 2014 by Wockhardt
Sponsor:
Information provided by (Responsible Party):
Wockhardt
ClinicalTrials.gov Identifier:
NCT01352663
First received: May 9, 2011
Last updated: May 28, 2014
Last verified: May 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is not yet open for participant recruitment.
  Estimated Study Completion Date: January 2017
  Estimated Primary Completion Date: July 2016 (Final data collection date for primary outcome measure)